Like dry eye, glaucoma is a long-term condition that doesn’t suddenly resolve overnight.
Vizo-PF Dorzolatim is the only preservative-free glaucoma drop treatment that’s available in a multi-dose bottle for convenience, ease of use, and reduced plastic waste when compared to single dose minims.
Vizo-PF Dorzolatim is listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate. It combines dorzolamide (as hydrochloride) 20 mg/mL and timolol (as maleate) 5 mg/mL.
Distributor AFT Pharmaceuticals also has approval for Vizo-PF Bimatotim 0.3/5 bimatoprost 300 µg/mL and timolol (as maleate) 5 mg/mL, and is planning to launch Vizo-PF Bimatoprost 300 µg/mL, which has been recommended for PBS listing.
Contact: AFT Pharmaceuticals (AUS) 02 9420 0420
